Katsarou Maria, Auyang Philip L, Chinnadurai Ponraj, Bismuth Jean
Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Section of Vascular Surgery, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
J Endovasc Ther. 2024 Feb;31(1):19-25. doi: 10.1177/15266028221113752. Epub 2022 Jul 22.
To demonstrate the feasibility of Octafen technique, a novel endovascular configuration for the treatment of thoracoabdominal aortic aneurysms (TAAA).
Two patients with complex TAAA and high surgical risk were treated with Octafen endograft configuration in a hybrid operating room with computed tomography (CT)-fluoroscopy image fusion guidance, using 3D-3D fusion techniques to facilitate procedural success. The procedure is a modification of the previously-described Octopus technique for endovascular repair of TAAA. The main advantage of this technique is the ability to use devices to repair a TAAA with the combination of off-the-shelf and noninvestigational custom-made devices. The devices used are readily available to most practicing vascular surgeons, which provides an alternative treatment in case of limited access to investigational devices, in time-sensitive cases, and in patients with limited functional capacity who cannot undergo open repair. In the modification described herein, we use a combination of standard bifurcated endovascular aneurysm repair (EVAR) devices (Excluder; W.L. Gore & Associates, Flagstaff, Arizona) in combination with a 2-vessel renal fenestrated device (Z-Fen; Cook Medical, Bloomington, Indiana). The article describes a step-by-step approach to this technique to elucidate pitfalls, benefits, and advantages.
The Octafen technique might offer an alternative option for thoracoabdominal aneurysm treatment circumventing the need for access to custom-made, investigational devices.
In this manuscript, we describe a technique for endovascular repair of thoraco-abdominal aortic aneurysms that involves the combination of off-the-shelf and non-investigational, custom-made devices. The 'Octafen' technique provides a treatment alternative in case of limited access to investigational devices and can be adjusted according to patient anatomy.
证明Octafen技术的可行性,这是一种用于治疗胸腹主动脉瘤(TAAA)的新型血管内配置。
两名患有复杂TAAA且手术风险高的患者在具有计算机断层扫描(CT)-荧光透视图像融合引导的杂交手术室中接受Octafen血管内移植物配置治疗,使用3D-3D融合技术促进手术成功。该手术是对先前描述的用于TAAA血管内修复的章鱼技术的改进。该技术的主要优点是能够使用现成的和非研究性定制设备组合来修复TAAA。大多数执业血管外科医生都可以轻松获得所使用的设备,这为在无法获得研究性设备、时间敏感的情况下以及功能能力有限无法接受开放修复的患者提供了一种替代治疗方法。在本文所述的改进中,我们使用标准分叉血管内动脉瘤修复(EVAR)设备(Excluder;W.L. Gore & Associates,弗拉格斯塔夫,亚利桑那州)与双血管肾开窗设备(Z-Fen;Cook Medical,布卢明顿,印第安纳州)的组合。本文描述了该技术的逐步方法,以阐明陷阱、益处和优势。
Octafen技术可能为胸腹主动脉瘤治疗提供一种替代选择,无需使用定制的研究性设备。
在本手稿中,我们描述了一种用于胸腹主动脉瘤血管内修复的技术,该技术涉及现成设备与非研究性定制设备的组合。“Octafen”技术在无法获得研究性设备的情况下提供了一种治疗选择,并且可以根据患者解剖结构进行调整。